Current progress and advances in hepatocellular carcinoma:highlights from the 2024 ESMO annual meeting
CHENG Yuan
DONG Pingping
GONG Xinlei
Abstract：The 2024 annual meeting of the European Society of Medical Oncology(ESMO)was held on September 13,2024 in Paris,France.This conference reported a number of important studies in the field of hepatocellular carcinoma(HCC),including advanced-stage systemic therapy,locoregional therapies in combination with systemic treatment for intermediate-stage HCC and adjuvant therapy for early stage.These results may change our clinical practice and promote the development of HCC.This article focuses on the research on HCC at the conference and discusses the hot spots,problems,and future directions.
Keywords：Hepatocellular carcinomaEuropean Society of Medical Oncology2024
Publication Date：2025-01-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 82-85 )